About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT05935397

HanYang University Medical Center (HYUMC) Registry

The HYUMC registry is a two-center, real-world registry of percutaneous coronary intervention in patients with coronary artery disease. From January 2012, PCI-treated patients from Hanyang University ...

Lead sponsor: Hanyang University Seoul Hospital•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Hanyang University Seoul Hospital

Collaborators

Hanyang University

In the HYUMC registry, the researchers have gathered and assessed various demographic, laboratory, echocardiographic, and angiographic measurements (both on-admission and during follow-up), as well as conducted questionnaires among patients who underwent percutaneous coronary intervention. The primary focus of this registry is to examine the effects of these parameters on long-term clinical outcomes.

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Consecutive patients with CAD who underwent PCI one or more drug eluting stent (DES) with from 2012 at the Division of Cardiology of Hanyang University Seoul Hospital and Hanyang University Guri Hospital, Korea.

Exclusion Criteria

•second or subsequent hospitalization records of patients with multiple admissions
•patients who died during index hospitalization
•patients who treated with first-generation drug eluting stent
•patients with an outpatient follow-up record of less than 6 months
•patients with insufficient medical records.

Related studies

Strategic Comparison Of Ischemia-based Versus Plaque Burden and vulnErability-based Revascularization in High-Risk Coronary Artery Disease Patients

NCT07324720 · Coronary Artery Disease

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

NCT07329699 · Coronary Artery Disease, Chronic Coronary Syndrome, and more

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

NCT06863155 · Coronary Artery Disease, Ischemic Heart Disease

RECRUITINGPhase 2/3

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

NCT04971720 · Obesity, Cardiovascular Diseases, and more

Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment

NCT07396636 · Intraoperative Hypotension, Perioperative Care, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 7, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment5,000

Start dateJan 2012

Last updatedJul 7, 2023

Condition

Coronary Artery Stenosis Coronary Artery Disease Blood Pressure

Locations shown

Hanyang University Guri Hospital

Guri-si

Hanyang University Seoul Hospital

Seoul

Young-Hyo Lim

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 7, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions